These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26771721)

  • 1. Drug-coated balloons: what is the evidence?
    Marques L; Hopf-Jensen S; Müller-Hülsbeck S
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):12-7. PubMed ID: 26771721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the potential limitations of drug coated balloons and possible ways to overcome.
    Werk M
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug coated balloons below-the-knee: just too early?
    Fanelli F; Cannavale A
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):18-22. PubMed ID: 26771722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments with drug-coated balloons.
    Tepe G
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):1-2. PubMed ID: 26771719
    [No Abstract]   [Full Text] [Related]  

  • 5. How does a drug-coated balloon work? Overview of coating techniques and their impact.
    Speck U; Stolzenburg N; Peters D; Scheller B
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):3-11. PubMed ID: 26771720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-stent restenosis: the gold standard has changed.
    Chin K
    EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
    Vaquerizo B; Serra A; Miranda-Guardiola F; Martínez V; Antoni Gómez-Hospital J; Iñiguez A; Fernández E; Ramón Rumoroso J; Bosa F; Otaegui I
    J Interv Cardiol; 2011 Dec; 24(6):518-28. PubMed ID: 21917013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
    Ju MH; Rodríguez HE
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloons in the lower limb.
    Zeller T; Schmitmeier S; Tepe G; Rastan A
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):235-43. PubMed ID: 21460774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
    Gandini R; Del Giudice C; Da Ros V; Sallustio F; Altobelli S; D'Onofrio A; Abrignani S; Vasili E; Stanzione P; Simonetti G
    J Endovasc Ther; 2014 Oct; 21(5):671-7. PubMed ID: 25290795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral applications of drug-coated balloons: past, present and future.
    Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
    Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.